A Pan‐Specific Inhibitor of the Polo‐Box Domains of Polo‐like Kinases Arrests Cancer Cells in Mitosis
- 25 April 2009
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 10 (7) , 1145-1148
Abstract
Playing polo: Small‐molecule inhibitors of polo‐like kinase 1 are mostly ATP‐competitive, and thus face enormous specificity hurdles. This communication explores the concept of inhibiting Plk1 with a small‐molecule inhibitor of the protein–protein interactions required for Plk1 function. magnified imageKeywords
This publication has 34 references indexed in Scilit:
- Polo on the Rise—from Mitotic Entry to Cytokinesis with Plk1Developmental Cell, 2008
- The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1Current Biology, 2007
- In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1Molecular Cancer Therapeutics, 2007
- Probing cell-division phenotype space and Polo-like kinase function using small moleculesNature Chemical Biology, 2006
- Targeting polo-like kinase 1 for cancer therapyNature Reviews Cancer, 2006
- Progress in the Discovery of Polo-like Kinase InhibitorsCurrent Topics in Medicinal Chemistry, 2005
- ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agentCancer Cell, 2005
- Wortmannin, a Widely Used Phosphoinositide 3-Kinase Inhibitor, also Potently Inhibits Mammalian Polo-like KinaseChemistry & Biology, 2005
- Polo-like kinases and the orchestration of cell divisionNature Reviews Molecular Cell Biology, 2004
- PLK (polo-like kinase), a new prognostic marker for oropharyngeal carcinomasInternational Journal of Cancer, 2000